Dermata Therapeutics, Inc. (DRMAW)
Dermata Therapeutics, Inc.
3525 Del Mar Heights Road
Suite 332
San Diego, CA 92130
United States
858 800 2543
https://www.dermatarx.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo: 8
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Gerald T. Proehl | Founder, President, CEO & Chairman | 392k | N/D | 1959 |
| Mr. David F. Hale | Co-Founder & Lead Independent Director | 73k | N/D | 1949 |
| Ms. Kyri K. Van Hoose CPA, M.B.A. | Senior VP & CFO | 415.8k | N/D | 1978 |
| Dr. Christopher J. Nardo M.P.H., Ph.D. | Senior VP & Chief Development Officer | 443.52k | N/D | 1965 |
| Mr. Sean Proehl | Senior Director of Legal & Business Development | N/D | N/D | N/D |
| Dr. Maria Bedoya Toro Munera M.B.A., Ph.D. | Senior Vice President of Regulatory Affairs & Quality Assurance | 27.04k | N/D | 1951 |
Descripción
Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of anxillary hyperhidrosis and aesthetic conditions. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Gestión corporativa
La calificación ISS Governance QuickScore de Dermata Therapeutics, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
